The emergence of mupirocin resistance: A challenge to infection control and antibiotic prescribing practice

Journal of Antimicrobial Chemotherapy

Volumn 41, Issue 1, 1998, Pages 11-18

  Cookson, Barry D ^a  

^a CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; METICILLIN; PSEUDOMONIC ACID;

ANTIBIOTIC RESISTANCE; GENETICS; INFECTION CONTROL; NOSE; PRESCRIPTION; REVIEW; SKIN INFECTION; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MICROBIAL; DRUG UTILIZATION; HUMANS; METHICILLIN RESISTANCE; MUPIROCIN; PHYSICIAN'S PRACTICE PATTERNS; SKIN DISEASES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 0031931007     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/41.1.11     Document Type: Review

References (62)

1. Cookson, B. D. (1990). Mupirocin resistance in staphylococci. Journal of Antimicrobial Chemotherapy 25, 497-501.
2. Hudson, I. R. (1994). The efficacy of intranasal mupirocin in the prevention of staphylococcal infections: a review of recent experience. Journal of Hospital Infection 27, 81-98.
3. Yanagisawa, T., Lee, J. T., Wu, H. C. & Kawakami, M. (1994). Relationship of protein structure of isoleucyl-tRNA synthetase with pseudomonic acid resistance of Escherichia coli. A proposed mode of action of pseudomonic acid as an inhibitor of isoleucyl-tRNA synthetase. Journal of Biological Chemistry 269, 24304-9.
4. Fuchs, P. C., Jones, R. N. & Barry, A. L. (1990). Interpretive criteria for disk diffusion susceptibility testing of mupirocin, a topical antibiotic. Journal of Clinical Microbiology 28, 608-9.
5. Doebbeling, B. & Boelart, J. (1994). Workshop one in staphylococcal infections: proceedings of an advisory workshop. Journal of Chemotherapy 6, Suppl. 2, 25.
6. Layton, M. C., Perez, M., Heald, P. & Patterson, J. E. (1993). An outbreak of mupirocin-resistant Staphylococcus aureus on a dermatology ward associated with an environmental reservoir. Infection Control and Hospital Epidemiology 14, 369-75.
7. Casewell, M. W. & Hill, R. L. R. (1987). Mupirocin ('pseudomonic acid') - a promising new topical antimicrobial agent. Journal of Antimicrobial Chemotherapy 19, 1-5.
8. Huskisson, S. C. & Wainscott, G. (1984). A comparative trial of mupirocin and chlortetracycline in general practice and a children's casualty department. In Mupirocin. A Novel Topical Antibiotic (Wilkinson, D. S. & Price, J. D., Eds), pp. 109-13. Royal Society of Medicine, London.
9. Rahman, M., Noble, W. C. & Cookson, B. D. (1987). Mupirocin-resistant Staphylococcus aureus. Lancet ii, 387.
10. Farmer, T. H., Gilbart, J. & Elson, S. W. (1992). Biochemical basis of mupirocin resistance in strains of Staphylococcus aureus. Journal of Antimicrobial Chemotherapy 30, 587-96.
11. Capobianco, J. O., Doran, C. C. & Goldman, R. C. (1989). Mechanism of mupirocin transport into sensitive and resistant bacteria. Antimicrobial Agents and Chemotherapy 33, 156-63.
12. Gilbart, J., Perry, C. R. & Slocombe, B. (1993). High-level mupirocin resistance in Staphylococcus aureus: evidence for two distinct isoleucyl-tRNA synthetases. Antimicrobial Agents and Chemotherapy 37, 32-8.
13. Baird, D. & Coia, J. (1987) Mupirocin-resistant Staphylococcus aureus. Lancet ii, 387-8.
14. Caspar, M. C., Sanchez, P., Uribe, P., Coello, R., Arroyo, P. & Cruzet, F. (1993). Mupirocin susceptibility in vitro and nasal eradication of epidemic methicillin-resistant Staphylococcus aureus. Journal of Hospital Infection 24, 237-8.
15. Redhead, R. J., Lamb, R. J. & Rowsell, R. B. (1991). The efficacy of calcium mupirocin in the eradication of nasal Staphylococcus aureus carriage. British Journal of Clinical Practice 45, 252-4.
16. Cookson, B. D. (1994). Antiseptic resistance in methicillin-resistant Staphylococcus aureus: an emerging problem. International Journal of Medical Microbiology, Suppl 26, 227-34.
17. Hodgson, J. E., Curnock, S. P., Dyke, K. G. H., Morris, R., Sylvester, D. R. & Gross, M. S. (1994). Molecular characterization of the gene encoding high-level mupirocin resistance in Staphylococcus aureus J2870. Antimicrobial Agents and Chemotherapy 38, 1205-8.
18. Bradley, S. F., Ramsey, M. A., Morton, T. M. & Kauffman, C. A. (1995). Mupirocin resistance: clinical and molecular epidemiology. Infection Control and Hospital Epidemiology 16, 354-8.
19. Slocombe, B. & Perry, C. (1991). The antimicrobial activity of mupirocin - an update on resistance. Journal of Hospital Infection 19, Suppl. B, 19-25.
20. Cookson, B. D., Farrelly, H., Stapleton, P., Garvey, R. P. J. & Price, M. R. (1991). Transferable resistance to triclosan in MRSA. Lancet 337, 1548-9.
21. Needham, C., Rahman, M., Dyke, K. G. & Noble, W. C. (1994). An investigation of plasmids from Staphylococcus aureus that mediate resistance to mupirocin and tetracycline. Microbiology 140, 2577-83.
22. Udo, E. E., Pearman, J. W. & Grubb, W. B. (1994). Emergence of high-level mupirocin resistance in methicillin-resistant Staphylococcus aureus in Western Australia. Journal of Hospital Infection 26, 157-65.
23. Ramsey, M. A., Bradley, S. F., Kauffman, C. A. & Morton, T. M. (1996). Identification of chromosomal location of mupA gene, encoding low-level mupirocin resistance in staphylococcal isolates. Antimicrobial Agents and Chemotherapy 40, 2820-3.
24. Slattery, J. T., Udo, E. E., Pearman, J. W., Riley, T. V. & Grubb, W. B. (1998). Mupirocin-resistant Staphylococcus aureus in Western Australia. Clinical Microbiology and Infection 3, Suppl. 2, Abstract P454, p. 105.
25. Morton, T. M., Johnston, J. L., Patterson, J. & Archer, G. L. (1995). Characterization of a conjugative staphylococcal mupirocin resistance plasmid. Antimicrobial Agents and Chemotherapy 39, 1272-80.
26. Cookson, B. D., Marples, R. R. & Speller, D. (1996). A questionnaire survey of mupirocin resistance (MuR) in the United Kingdom. In Proceedings of the Eighth International Symposium on Staphylococci and Staphylococcal Infections, Aix-les-Bains, France, 1996. Poster 234, p. 247.
27. Berger-Bächi, B., Strassle, A., Gustafson, J. E. & Kayser, F. H. (1992). Mapping and characterization of multiple chromosomal factors involved in methicillin resistance in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 36, 1367-73.
28. Cookson, B. D., Lacey, R. W., Noble, W. C., Reeves, D. S., Wise, R. & Redhead, R. J. (1990). Mupirocin-resistant Staphylococcus aureus. Lancet 335, 1095-6.
29. Wise, R. & Johnson, J. (1991). Mupirocin resistance. Lancet 338, 578.
30. Cookson, B., Farrelly, H., Palepou, M. F. & George, R. (1992). Mupirocin-resistant Staphylococcus aureus. Lancet 339, 625.
31. Gu, J. W., Briones, F., Fang, W., Scully, B. E. & Neu, H. C. (1991). Susceptibility of 1309 nasal isolates of Staphylococcus aureus from hospital personnel in the United States to 21 antibiotics. American Society for Microbiology Meeting, Dallas, 1991. Abstract A97.
32. Hefferman, H., Davies, H. & Brett, M. (1995). MRSA increasing in New Zealand. New Zealand Public Health Report 2, 97-9.
33. Riley, T. V., Carson, C. F., Bowman, R. A., Mulgrave, L., Golledge, C. L., Pearman, J. W. et al. (1994). Mupirocin-resistant methicillin-resistant Staphylococcus aureus in Western Australia. Medical Journal of Australia 161, 397-8.
34. Alarcon, T., Sanz, J. C., Domingo, S., Blanco, F. & Lopez Brea, M. (1996). High level mupirocin resistance S. aureus from Spain. In Programme of the First European Congress of Chemotherapy, Glasgow, 1996. Abstract T172, London.
35. Miller M. A., Dascal, A., Portnoy, J. & Mendelson J. (1996). Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment. Infection Control and Hospital Epidermiology 17, 811-3.
36. Netto dos Santos, K. R., de Souza Fonseca, L. & Gontÿo Filho, P. P. (1996). Emergence of high-level mupirocin resistance in methicilin-resistant Staphylococcus aureus isolated from Brazilian university hospitals. Infection Control and Hospital Epidemiology 17, 813-6.
37. Leski, T., Skoczynska, A. & Hryniewcz, W. (1997). Epidemiological analysis of mupirocin-resistant Staphylococcus spp. using molecular methods. Clinical Microbiology and Infection ECCMID Abstracts 3, 99, Abstract 433.
38. Rahman, M., Noble, W. C. & Dyke, K. G. (1993). Probes for the study of mupirocin resistance in staphylococci. Journal of Medical Microbiology 39, 446-9.
39. Woodford, N., Watson, A. P., Patel, S., Waghorn, D. J. & Cookson, B. D. (1996). Heterogeneous location of the novel mupA gene which confers high-level mupirocin resistance in Staphylococcus aureus. In Proceedings of the Eighth International Symposium on Staphylococci and Staphylococcal Infections. Aixles-Bains, France, 1996. Poster 198, p. 238.
40. Marples, R. R., Speller, D. C. & Cookson, B. D. (1995). Prevalence of mupirocin resistance in Staphylococcus aureus. Journal of Hospital Infection 29, 153-5.
41. Combined Working Party of the Hospital Infection Society and the British Society of Antimicrobial Chemotherapy. (1990). Revised guidelines for the control of epidemic methicillin-resistant Staphylococcus aureus. Journal of Hospital Infection 16, 351-77.
42. Irish, D., Eltringham, I., Teall, A., Pickett, H., Farrelly, H., Reith, S. et al. (1998). Control of an outbreak of an epidemic methicillin and mupirocin resistant Staphylococcus aureus. Journal of Hospital Infection, in press.
43. Connolly, S., Noble, W. C. & Phillips, I. (1993). Mupirocin resistance in coagulase-negative staphylococci. Journal of Medical Microbiology 39, 450-3.
44. Udo, E. E., Jacob, L. E. & Mokadas, E. M. (1997). Conjugative transfer of high-level mupirocin resistance from Staphylococcus haemolyticus to other staphylococci. Antimicrobial Agents and Chemotherapy 41, 693-5.
45. Wu, S., Piscitelli, C., de Lencastre, H. & Tomasz, A. (1996). Tracking the evolutionary origin of the methicillin resistance gene: cloning and sequencing of a homologue of mecA from a methicillin susceptible strain of Staphylococcus sciuri. Microbial Drug Resistance 2, 435-441.
46. Maple, P. A., Hamilton-Miller, J. M. & Brumfitt, W. (1992). Comparison of the in-vitro activities of the topical antimicrobials azelaic acid, nitrofurazone, silver sulphadiazine and mupirocin against methicillin-resistant Staphylococcus aureus. Journal of Antimicrobial Chemotherapy 29, 661-8.
47. Woodford, N., Patel, S., Johnson, A. P., Farrelly, H. & Cookson, B. (1993). In vitro activity of ramoplanin against mupirocin-sensitive and mupirocin-resistant Staphylococcus aureus. In Program and Abstracts of the 33rd Conference or International Conference on Antimicrobial Agents and Chemotherapy New Orleans, LA. Abstract 1036, p. 309.
48. Chapnick, E. K., Gradon, J. D., Kreiswirth, B., Lutwick, L. I., Schaffer, B. C., Schiano, T. D. et al. (1996). Comparative killing Kinetics of methicillin-resistant Staphylococcus aureus by bacitracin or mupirocin. Infection Control and Hospital Epidemiology 17, 178-80.
49. Carson, C. F., Cookson, B. D., Farrelly, H. D. & Riley, T. V. (1995) Susceptibility of methicillin-resistant Staphylococcus aureus to the essential oil of Melaleuca alternifolia. Journal of Antimicrobial Chemotherapy 35, 421-4.
50. Hammer, K. A., Carson, C. F. & Riley, T. V. (1996). Susceptibility of transient and commensal skin flora to the essential oil of Melaleuca alternifolia (tea tree oil). American Journal of Infection Control 24, 186-9.
51. Saji, M., Taguchi, S., Uchiyama, K., Osono, E., Havanna N. & Ohkuni, H. (1995). Efficacy of gentian violet in the eradication of methicillin-resistant Staphylococcus aureus from skin lesions. Journal of Hospital Infection 31, 225-8.
52. Shiozawa, H., Kagasaki, T., Kinoshita, T., Haruyama, H., Domon, H., Utsui, Y. et al. (1993). Thiomarinol, a new hybrid antimicrobial antibiotic produced by a marine bacterium. Fermentation, isolation, structure, and antimicrobial activity. Journal of Antibiotics 46, 1834-42.
53. MacDonald, D., Jones, L. & Messler, C. (1993). Comparison of topical agents magainin MSI-78 and mupirocin. Potential for resistance development in Staphylococcus aureus. In Abstracts of the 33rd International Conference on Antimicrobial Agents and Chemotherapy, New Orleans, LA. Abstract 1037, p. 309.
54. Dembry, L. M., Uzokwe, K. & Zervos, M. J. (1996). Control of endemic glycopeptide-resistant enterococci. Infection Control and Hospital Epidemiology 17, 286-92.
55. Dawson, S. J., Finn, L. F., McCulloch, J. E., Kilvington, S. & Lewis, D. A. (1994). Mupirocin-resistant MRSA. Journal of Hospital Infection 28, 75-8.
56. Ambler, J. E. & Drabu, Y. J. (1996). Mupirocin-resistant methicillin-resistant Staphylococcus aureus. Journal of Hospital Infection 32, 71-82.
57. Boyce, S. T., Warden, G. D. & Holder, L. A. (1995). Cytotoxicity testing of topical antimicrobial agents on human keratinocytes and fibroblasts for cultured skin grafts. Journal of Burn Care and Rehabilitation 16, 97-103.
58. VandenBergh, M. F. O., Kluytmans, J. A. J. W.., van Hout, B. A., Maat, A. P. W. M., Seerden, R. J., McDonnel, J. et al. (1996). Cost-effectiveness of perioperative mupirocin nasal ointment in cardiothoracic surgery. Infection Control and Hospital Epidemiology 17, 786-92.
59. Kauffman, C. A., Terpenning, M. S., He, X., Zarins, L. T., Ramsey, M. A., Jorgensen, K. A. et al. (1993). Attempts to eradicate methicillin-resistant Staphylococcus aureus from a long-term-care facility with the use of mupirocin ointment. American Journal of Medicine 94, 371-8.
60. Mayall, B., Martin, R., Keenan, A. M., Irving, L., Leeson, P. & Lamb, K. (1996). Blanket use of intranasal mupirocin for outbreak control and long-term prophylaxis of endemic methicillin-resistant Staphylococcus aureus in an open ward. Journal of Hospital Infection 32, 257-66.
61. Pearson, S. & Mayall, B. (1966). Short term occurrence of mupirocin resistance during blanket mupirocin prophylaxis for MRSA. In Proceedings of the Eighth International Symposium on Staphylococci and Staphylococcal Infections, Aix-les-Bains, 1996. Poster 254, p. 252.
62. Péchère, J. C. (1994). Antibiotic resistance is selected primarily in out patients. Infection Control and Hospital Epidemiology 15, 472-7.